 |
|
|
| |
Real-world Utilization and Adherence of Cabotegravir Long-Acting for HIV Pre-Exposure Prophylaxis in the United States: Results From the PrEPFACTS Study Using Healthcare Administrative Claims Data
|
| |
| |
13th IAS Conference on HIV Science; July 13-17, 2025; Kigali, Rwanda
Aimee A. Metzner,1
|
| |
|
|
|
|
|
